. "Blok\u00E1tory v\u00E1pn\u00EDkov\u00FDch kan\u00E1l\u016F inhibuj\u00ED pr\u016Fnik v\u00E1pn\u00EDkov\u00FDch iont\u016F do bun\u011Bk myokardu, p\u0159evodn\u00EDho syst\u00E9mu i hladk\u00E9ho svalstva c\u00E9vn\u00ED st\u011Bny. Indikuj\u00ED se p\u0159edev\u0161\u00EDm v l\u00E9\u010Db\u011B syst\u00E9mov\u00E9 hypertenze, kdy lze z prepar\u00E1t\u016F vyb\u00EDrat bez v\u011Bt\u0161\u00EDho omezen\u00ED. Mezi jejich dal\u0161\u00ED indikace pat\u0159\u00ED supraventrikul\u00E1rn\u00ED tachykardie, hypertrofick\u00E1 kardiomyopatie (u obou verapamil, diltiazem), p\u0159\u00EDpadn\u011B stabilizovan\u00E1 angina pectoris. Verapamil s diltiazemem lze pou\u017E\u00EDt jen u osob bez dysfunkce lev\u00E9 komory. V\u017Edy p\u0159ich\u00E1z\u00ED v \u00FAvahu pouze l\u00E9kov\u00E9 formy s \u0159\u00EDzen\u00FDm uvol\u0148ov\u00E1n\u00EDm, v \u017E\u00E1dn\u00E9 indikaci se dnes ji\u017E nepou\u017E\u00EDvaj\u00ED kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED prepar\u00E1ty typu nedostate\u010Dn\u011B retardovan\u00E9ho nifedipinu"@cs . . . "The calcium channel blockers inhibit the influx of calcium ions into myocardial cells, conduction system and vascular smooth muscle. They are indicated for use in the treatment of systemic hypertension and their choice is not substantially Iimited. Other indications are supraventricular tachycardia, hypertrophic cardiomyopathy (with verapamil and diltiazem used in both indications), and possibly stable angina pectoris. Verapamil and diltiazem can only be used in patients without left ventricular dysfunction. The controlled-release dosage forms are the only ones to be considered, as short-acting agents such as short-release nifedipine are no more used in any indication"@en . "RIV/00064173:_____/11:#0000118" . . "Blok\u00E1tory v\u00E1pn\u00EDkov\u00FDch kan\u00E1l\u016F a jejich sou\u010Dasn\u00E9 m\u00EDsto v kardiologii" . . "188515" . . . . . "Blok\u00E1tory v\u00E1pn\u00EDkov\u00FDch kan\u00E1l\u016F a jejich sou\u010Dasn\u00E9 m\u00EDsto v kardiologii"@cs . "2" . "calcium channel blockers, hypertension, hypertrophic cardiomyopathy, left ventricular dysfunction"@en . . "4"^^ . "Calc\u00EDum channel blockers and the\u00EDr current place \u00EDn card\u00EDology"@en . "Calc\u00EDum channel blockers and the\u00EDr current place \u00EDn card\u00EDology"@en . . . "Blok\u00E1tory v\u00E1pn\u00EDkov\u00FDch kan\u00E1l\u016F a jejich sou\u010Dasn\u00E9 m\u00EDsto v kardiologii" . "CZ - \u010Cesk\u00E1 republika" . "Remedia" . "1"^^ . "[4E780285089A]" . "0862-8947" . "1"^^ . . "RIV/00064173:_____/11:#0000118!RIV12-MZ0-00064173" . "Blok\u00E1tory v\u00E1pn\u00EDkov\u00FDch kan\u00E1l\u016F a jejich sou\u010Dasn\u00E9 m\u00EDsto v kardiologii"@cs . . "21" . . "Blok\u00E1tory v\u00E1pn\u00EDkov\u00FDch kan\u00E1l\u016F inhibuj\u00ED pr\u016Fnik v\u00E1pn\u00EDkov\u00FDch iont\u016F do bun\u011Bk myokardu, p\u0159evodn\u00EDho syst\u00E9mu i hladk\u00E9ho svalstva c\u00E9vn\u00ED st\u011Bny. Indikuj\u00ED se p\u0159edev\u0161\u00EDm v l\u00E9\u010Db\u011B syst\u00E9mov\u00E9 hypertenze, kdy lze z prepar\u00E1t\u016F vyb\u00EDrat bez v\u011Bt\u0161\u00EDho omezen\u00ED. Mezi jejich dal\u0161\u00ED indikace pat\u0159\u00ED supraventrikul\u00E1rn\u00ED tachykardie, hypertrofick\u00E1 kardiomyopatie (u obou verapamil, diltiazem), p\u0159\u00EDpadn\u011B stabilizovan\u00E1 angina pectoris. Verapamil s diltiazemem lze pou\u017E\u00EDt jen u osob bez dysfunkce lev\u00E9 komory. V\u017Edy p\u0159ich\u00E1z\u00ED v \u00FAvahu pouze l\u00E9kov\u00E9 formy s \u0159\u00EDzen\u00FDm uvol\u0148ov\u00E1n\u00EDm, v \u017E\u00E1dn\u00E9 indikaci se dnes ji\u017E nepou\u017E\u00EDvaj\u00ED kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED prepar\u00E1ty typu nedostate\u010Dn\u011B retardovan\u00E9ho nifedipinu" . "Gregor, P." . . "I" .